Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|March 23, 2017

PPD Launches CRA Apprenticeship Program

Launches program in North Carolina, California and Texas with a focus on military veterans and service members transitioning to civilian careers

Wilmington, N.C. – Pharmaceutical Product Development, LLC (PPD) today announced its launch of a clinical research associates (CRAs) apprenticeship program targeted to military veterans and military service members with medical backgrounds who are transitioning to the civilian workforce. PPD’s initiative, the first CRA apprenticeship program registered with the U.S. Department of Labor, will begin in North Carolina, Texas and California in the first quarter of this year.

“As a veteran who transitioned to the civilian workforce, I understand the need to provide viable career opportunities to those who have served,” said William Sharbaugh, chief operating officer of PPD. “Our industry-first CRA apprenticeship program recognizes the skills of veterans and transitioning service members with medical backgrounds who, through their service, have developed the requisite skills of leadership and who are motivated to join us in helping deliver life-changing medicines.”

PPD’s 12-month program, which provides training through PPD’s award-winning CRA academy and on-the-job learning, is designed to give participants the foundation to be qualified and successful CRAs. The competency-based program provides exposure to three clinical roles, allowing apprentices to build on what they’ve learned and gradually integrate into the contract research industry.

“PPD recognizes the need for highly skilled professionals to ensure the quality of clinical trials,” said Ed Murray, executive vice president and chief human resources officer of PPD. “With this program, PPD addresses one of the immediate needs of military veterans and personnel transitioning to civilian careers, while addressing a clear need to expand the talent pool of CRAs for the conduct of clinical research.”  

NCWorks, the North Carolina approving agency for the U.S. Department of Labor, and the Office of Apprenticeship in California and in Texas approved PPD’s application to make the role of clinical research associate (clinical documentation improvement specialist) a recognized occupation for registered apprenticeship programs.

PPD is responsible for the coordination, administrative processes and all programming aspects, including recruitment and marketing, of the apprenticeship. In establishing the program, PPD draws on decades of experience in recruiting and developing CRAs. In 2016 PPD won the Outstanding Training Initiative Award for its Virtual Clinical Foundations Program 2.0, which prepares CRAs for success in monitoring clinical trials.

About PPD
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and more than 18,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health. For more information, visit www.ppdi.com.


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.